Literature DB >> 9600220

Third ventricular chordoid glioma: a distinct clinicopathologic entity.

D J Brat1, B W Scheithauer, S M Staugaitis, S C Cortez, K Brecher, P C Burger.   

Abstract

We have encountered a series of 8 third ventricular neoplasms with a distinctive chordoid appearance that appear to represent a clinicopathologic entity. The tumors occurred in 7 females and 1 male, ranging in age from 31 to 70 years. In all cases, imaging studies showed a large well-circumscribed third ventricular mass; a cystic component was noted in 2. The tumors consisted of cords and clusters of cohesive, oval-to-polygonal epithelioid cells with abundant eosinophilic cytoplasm, relatively uniform round-to-oval nuclei, and inconspicuous nucleoli. Mitotic activity was absent. The stroma consisted of scant, coarse fibrillar processes, as well as prominent, slightly basophilic, extracellular mucin resembling that in chordomas. Throughout the tumor, and surrounding its well-defined borders, were infiltrates of mature lymphocytes and plasma cells. Russell bodies were prominent in the latter. Adjacent brain tissue showed reactive changes with gliosis and numerous Rosenthal fibers. Immunohistochemically, tumor cells were strongly reactive for GFAP and vimentin, but negative or only weakly staining for EMA. The MIB-1 labeling index was approximately 1%. Ultrastructural examination of 4 cases revealed focal microvilli, scattered "intermediate" junctions, and focal basal lamina formation. Neither desmosomes nor cilia were seen. Total resections were achieved in 2 cases; only subtotal removals were achieved in 6. Subsequent tumor enlargement was noted in 3 of the 6 patients with incomplete resection, and of these, two died at post-operative intervals of 8 months and 3 years. The other patient survives 4 years post-operatively with stable residual disease. Of the 2 patients with total resection, 1 was lost to follow-up; the other, during a brief follow-up period, did well without evidence of recurrence.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9600220     DOI: 10.1097/00005072-199803000-00009

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  27 in total

1.  Suprasellar monomorphous pilomyxoid gliomas.

Authors:  Carol K Petito
Journal:  AJNR Am J Neuroradiol       Date:  2003 Nov-Dec       Impact factor: 3.825

Review 2.  Prognostic factors for recurrence and complications in the surgical management of primary chordoid gliomas: A systematic review of literature.

Authors:  Leonel Ampie; Winward Choy; Jonathan B Lamano; Kartik Kesavabhotla; Qinwen Mao; Andrew T Parsa; Orin Bloch
Journal:  Clin Neurol Neurosurg       Date:  2015-08-19       Impact factor: 1.876

3.  Chordoid glioma.

Authors:  Lakana Kumar Thavaratnam; Shun Ting Loy; Arvind Gupta; Ivan Ng; James F Cullen
Journal:  Singapore Med J       Date:  2015-11       Impact factor: 1.858

4.  Distinguishing chordoid meningiomas from their histologic mimics: an immunohistochemical evaluation.

Authors:  Ankur R Sangoi; Mohanpal S Dulai; Andrew H Beck; Daniel J Brat; Hannes Vogel
Journal:  Am J Surg Pathol       Date:  2009-05       Impact factor: 6.394

5.  Chordoid glioma of the third ventricle: report of a rapidly progressive case.

Authors:  Amalie A Erwood; Jose E Velazquez-Vega; Stewart Neill; David A Solomon; Nicholas Butowski; Adam Nowlan; Erin Dunbar; Daniel J Brat
Journal:  J Neurooncol       Date:  2017-03-18       Impact factor: 4.130

6.  Chordoid glioma: a neoplasm unique to the hypothalamus and anterior third ventricle.

Authors:  M G Pomper; T J Passe; P C Burger; B W Scheithauer; D J Brat
Journal:  AJNR Am J Neuroradiol       Date:  2001-03       Impact factor: 3.825

7.  Neurogenic fever in a patient with a chordoid glioma.

Authors:  Rafael García Carretero; Marta Romero Brugera; Oscar Vazquez-Gomez; Noelia Rebollo-Aparicio
Journal:  BMJ Case Rep       Date:  2016-11-17

8.  Freiburg Neuropathology Case Conference : Tumor Located in the Anterior Portion of the Third Ventricle.

Authors:  C A Taschner; P Süß; M Hohenhaus; H Urbach; N Lützen; M Prinz
Journal:  Clin Neuroradiol       Date:  2018-03       Impact factor: 3.649

9.  Expanded Endoscopic Transnasal Approach to the Chordoid Glioma of the Third Ventricle : The First Case Ever Reported.

Authors:  Mehdi Zeinalizadeh; Seyed Mousa Sadrehosseini; Keyvan Tayebi Meybodi; Ali Heidari Sharifabadi
Journal:  J Korean Neurosurg Soc       Date:  2016-10-24

Review 10.  Chordoid glioma of the third ventricle: a patient presenting with SIADH and a review of this rare tumor.

Authors:  Matilde Calanchini; Simon Cudlip; Monika Hofer; James Byrne; Andrea Fabbri; Ashley Grossman
Journal:  Pituitary       Date:  2016-08       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.